Literature DB >> 22870114

ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy.

Luiza Kanczuga-Koda1, Mariusz Koda, Jakub Tomaszewski, Katarzyna Jarzabek, Joanna Lotowska, Marek Baltaziak, Urszula Sulkowska, Maria Sobaniec-Lotowska, Stanisław Sulkowski.   

Abstract

This study aimed to assess the pre-operative chemotherapy impact on the relationship between estrogen receptor (ER) expression and markers of proliferation and apoptosis in primary and metastatic breast cancer. Immunohistochemical examinations were conducted on surgically removed ductal invasive breast cancers and their lymph node metastases in 135 patients. A total of 64 patients from this group underwent pre-operative chemotherapy and in 71 cases the surgery was performed without primary chemotherapy. A negative correlation between ERα and Ki-67 was found in primary tumors and lymph node metastases. A positive correlation was observed between ERα and Bcl-2. A positive correlation was also noted between ERβ and Bak, suggesting that the two ERs were involved in the regulation of proteins responsible for the control of the apoptotic process. Assessment of the expression of the proteins conducted separately in primary tumors and lymph node metastases did not reveal a significant effect of pre-operative chemotherapy on the correlations of ERs with Ki-67, Bcl-2 and Bak. However, the analysis of the correlations between the receptor expression in primary tumors and Ki-67, Bcl-2 and Bak in lymph node metastases showed a statistically significant impact of pre-operative chemotherapy on the correlations of ERα and Bcl-2 with ERβ and Bak, confirming involvement of the two ERs in the regulation of apoptosis during breast carcinogenesis.

Entities:  

Year:  2010        PMID: 22870114      PMCID: PMC3412501          DOI: 10.3892/ol.2010.178

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.

Authors:  Mariusz Koda; Andrzej Lenczewski; Mariola Sulkowska; Luiza Kanczuga-Koda; Andrzej Wincewicz; Jakub Tomaszewski; Stanislaw Sulkowski
Journal:  Oncol Rep       Date:  2007-02       Impact factor: 3.906

2.  In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.

Authors:  P Rochaix; S Krajewski; J C Reed; F Bonnet; J J Voigt; P Brousset
Journal:  J Pathol       Date:  1999-03       Impact factor: 7.996

3.  Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer.

Authors:  Mariusz Koda; Wojciech Przystupa; Katarzyna Jarzabek; Andrzej Wincewicz; Luiza Kanczuga-Koda; Jakub Tomaszewski; Mariola Sulkowska; Slawomir Wolczynski; Stanislaw Sulkowski
Journal:  Oncol Rep       Date:  2005-07       Impact factor: 3.906

4.  Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases.

Authors:  M Koda; M Sulkowska; L Kanczuga-Koda; S Sulkowski
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

5.  bcl-2 and apoptosis in lymph node positive breast carcinoma.

Authors:  M D Berardo; R M Elledge; C de Moor; G M Clark; C K Osborne; D C Allred
Journal:  Cancer       Date:  1998-04-01       Impact factor: 6.860

Review 6.  Overview of resistance to systemic therapy in patients with breast cancer.

Authors:  Ana Maria Gonzalez-Angulo; Flavia Morales-Vasquez; Gabriel N Hortobagyi
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

7.  Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.

Authors:  Julie M Wu; Mary Jo Fackler; Marc K Halushka; Diana W Molavi; M Evangeline Taylor; Wei Wen Teo; Constance Griffin; John Fetting; Nancy E Davidson; Angelo M De Marzo; Jessica L Hicks; Dhananjay Chitale; Marc Ladanyi; Saraswati Sukumar; Pedram Argani
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

Review 8.  Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.

Authors:  Richard J Santen; Ping Fan; Zhenguo Zhang; Yongde Bao; Robert X-D Song; Wei Yue
Journal:  Steroids       Date:  2008-12-07       Impact factor: 2.668

9.  Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials.

Authors:  Uwe Gueth; Dorothy Jane Huang; Andreas Schoetzau; Wolfgang Holzgreve; Edward Wight
Journal:  Oncology       Date:  2009-02-25       Impact factor: 2.935

10.  The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.

Authors:  Mariusz Koda; Mariola Sulkowska; Luiza Kanczuga-Koda; Jakub Tomaszewski; Waldemar Kucharczuk; Tomasz Lesniewicz; Slawomir Cymek; Stanislaw Sulkowski
Journal:  Oncol Rep       Date:  2007-07       Impact factor: 3.906

View more
  2 in total

1.  High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.

Authors:  Yanwei Luo; Xinye Wang; Heran Wang; Yang Xu; Qiuyuan Wen; Songqing Fan; Ran Zhao; Shihe Jiang; Jing Yang; Yukun Liu; Xiayu Li; Wei Xiong; Jian Ma; Shuping Peng; Zhaoyang Zeng; Xiaoling Li; Joshua B Phillips; Guiyuan Li; Ming Tan; Ming Zhou
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

2.  Estrogen regulation of anti-apoptotic Bcl-2 family member Mcl-1 expression in breast cancer cells.

Authors:  Jennifer L Schacter; Elizabeth S Henson; Spencer B Gibson
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.